UBT48128 / United Laboratories - LARVOL DELTA

…The United Bio-Technology (Hengqin) Co., Ltd., has received U.S. Food and Drug Administration approval of Investigational New Drug applications for UBT48128 Tablets (TipRanks) - "The small-molecule GLP-1 receptor agonist is intended for treating overweight or obesity and type 2 diabetes, reflecting the group’s strategic emphasis on innovative chronic disease therapies."

IND • Obesity • Type 2 Diabetes Mellitus